Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
基本信息
- 批准号:10735154
- 负责人:
- 金额:$ 19.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-12 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAflatoxin B1Alkylating AgentsAlkylationAntineoplastic AgentsBase Excision RepairsBase PairingBiochemicalBiologicalBiological AssayBypassCandidate Disease GeneCarcinogensCatalysisCellsChargeChemicalsChemistryComplexDNADNA AlkylationDNA DamageDNA MaintenanceDNA Modification ProcessDNA StructureDNA biosynthesisDNA glycosylaseDNA-Directed DNA PolymeraseDepurinationDevelopmentDissociationEquilibriumEtiologyExcisionFluorineFrequenciesGenesGenetic TranscriptionGoalsGuanineHeterogeneityHourHumanImidazoleIn VitroIndividualInduced MutationIsomerismKetonesKineticsKnowledgeLesionLightMalignant NeoplasmsMechlorethamineMediatingModificationMolecular ConformationMutagenesisMutagensMutationNicotineNitrosaminesNucleosidesNucleotidesPharmaceutical PreparationsPhasePlasmidsPolymeraseProcessPropertyPublic HealthPublishingRelaxationReporterReportingResearchRoleSecondary LesionSiteSolidStructureSystemTechnologyTestingTobaccoadductanomerantitumor agentbasecarcinogenesisendonucleaseenolgenotoxicityin vivoinnovationinsightintercalationionizationknock-downmeltingmutation assaynucleotide metabolismpreventprogramsrepair modelrepairedstructural biologystyrene oxidesuccesssynthetic constructtautomertool
项目摘要
ABSTRACT
Alkylation DNA damage caused by alkylating agents promotes mutations and cancer development. Guanine N7
is targeted by a wide range of alkylating mutagens, carcinogens, and anticancer agents, producing the cationic
N7-alkylguanine (N7-alkylG) adducts as major lesions. These lesions have half-lives of several hours to days in
DNA and thus can affect DNA replication and transcription. The positively charged N7-alkylG lesions can also
undergo further modification to generate secondary lesions such as alkyl-formamidopyrimidine (alkyl-FapyG)
adducts. The recognition, repair, and mutagenesis mechanisms of many mutagen/carcinogen-induced N7-
alkylG and alkyl-FapyG lesions, except for a few lesions such as N7-aflatoxin B1-G and aflatoxin B1-FapyG
adducts, remain poorly characterized, thereby precluding a complete understanding of the contribution of these
major lesions to mutations and cancer development. For example, the mutagenic properties of the predominant
N7-alkylG adducts produced by the cancer-promoting styrene oxide are unknown. This knowledge gap has
been due in part to the technical difficulty in preparing a site-specific N7-alkylG- and alkyl-FapyG-containing
DNA, which is ascribed to the rapid depurination of N7-alkylG nucleosides and the facile isomerization of alkyl-
FapyG during solid-phase DNA synthesis. To overcome the stability issue of N7-alkylG nucleosides, we have
developed a 2’-fluorine technology that prevents spontaneous depurination by increasing the stability of N7-
alkylG nucleosides. To solve the isomerization problem of alkyl-FapyG, we have taken a post-synthetic
approach that produces alkyl-FapyG-containing DNA from N7-alkylG-containing DNA. Our preliminary studies
show that guanine N7 alkylation can influence base-pairing properties by facilitating the formation of the rare
enol tautomer, syn base conformation, and/or intercalation. Our central hypothesis is that N7-alkylG and alkyl-
FapyG adducts promote mutations and cancer development by altering the base-pairing properties of the
damaged guanine. Our long-term research goal is to elucidate the biological impacts of chemically labile
alkylation damages and their secondary lesions using innovative approaches such as the 2’-F chemistry, the
polβ host-guest-complex system, and post-synthetic DNA modification. The objective is to dissect the biological
consequences of N7-alkylG and alkyl-FapyG lesions induced by potent alkylating mutagens and anticancer
agents such as nicotine-specific nitrosamine, styrene oxide, nitrogen mustards, and N-methylbenzyl nitrosamine.
To accomplish this objective, we will characterize the base-pairing properties and the recognition, mutagenesis,
and repair mechanisms of N7-alkylG and alkyl-FapyG adducts using combined tools of synthetic, biochemical,
structural biology, and cellular approaches. The successful execution of the proposed programs will greatly
advance our knowledge of the impact of carcinogen/drug-induced N7-alkylG and alkyl-FapyG lesions on the
base pair conformation, stability, tautomerism, mutagenesis, recognition, and repair, thereby providing important
insights into the alkylation damage-induced mutations and cancer development.
摘要
由烷化剂引起的烷化剂DNA损伤促进突变和癌症发展。鸟嘌呤N7
被广泛的烷基化诱变剂、致癌剂和抗癌剂靶向,产生阳离子
N7-烷基鸟嘌呤(N7-alkylG)加合物为主要病变。这些病变的半衰期为数小时至数天,
因此可以影响DNA的复制和转录。带正电荷的N7-烷基G损伤也可以
进行进一步修饰以产生继发性损伤,如烷基-甲酰胺基嘧啶(烷基-FapyG)
加合物许多致突变剂/致癌物诱导的N7-的识别、修复和致突变机制
烷基G和烷基-FapyG病变,除了少数病变如N7-黄曲霉毒素B1-G和黄曲霉毒素B1-FapyG
加合物,仍然很差的特点,从而排除了一个完整的了解这些贡献,
突变和癌症发展的主要病变。例如,占主导地位的
由促进癌症的氧化苯乙烯产生的N7-烷基G加合物是未知的。这种知识差距
部分是由于制备位点特异性的含N7-烷基G-和烷基-FapyG-的化合物的技术困难,
DNA,这归因于N7-烷基G核苷的快速脱嘌呤和烷基G核苷的容易异构化。
固相DNA合成过程中的FapyG。为了克服N7-烷基G核苷的稳定性问题,我们
开发了一种2 '-氟技术,通过增加N7-的稳定性来防止自发脱嘌呤。
烷基G核苷。为了解决烷基-FapyG的异构化问题,我们采取了后合成方法,
从含N7-烷基G的DNA产生含烷基-FapyG的DNA的方法。我们的初步研究
表明鸟嘌呤N7烷基化可以通过促进稀有碱基的形成来影响碱基配对特性,
烯醇互变异构体、顺式碱构象和/或插层。我们的中心假设是N7-烷基G和烷基-
FapyG加合物通过改变FapyG的碱基配对特性来促进突变和癌症发展。
损坏的鸟嘌呤。我们的长期研究目标是阐明化学不稳定的生物学影响,
烷基化损伤及其继发性损伤,使用创新的方法,如2 '-F化学,
polβ主客体复合物体系和DNA合成后修饰。我们的目标是剖析
由强效烷化剂和抗癌诱变剂诱导的N7-烷基G和烷基-FapyG病变的后果
试剂如烟碱特异性亚硝胺、氧化苯乙烯、氮芥和N-甲基苄基亚硝胺。
为了实现这一目标,我们将表征碱基配对特性和识别,诱变,
和N7-烷基G和烷基-FapyG加合物的修复机制,
结构生物学和细胞方法。成功执行拟议的方案将大大
推进我们对致癌物/药物诱导的N7-alkylG和alkyl-FapyG病变对
碱基对构象,稳定性,互变异构,诱变,识别和修复,从而提供重要的
深入了解烷基化损伤诱导的突变和癌症发展。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seongmin Lee其他文献
Seongmin Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seongmin Lee', 18)}}的其他基金
Studies of Chemically Labile Alkylation Damage in DNA
DNA 中化学不稳定烷基化损伤的研究
- 批准号:
10769108 - 财政年份:2023
- 资助金额:
$ 19.37万 - 项目类别:
Synthesis, structure and biological effects of carcinogen/drug-induced bulky, intercalatable N7-alkylguanine lesions
致癌物/药物引起的大块插入式N7-烷基鸟嘌呤损伤的合成、结构和生物学效应
- 批准号:
9754147 - 财政年份:2017
- 资助金额:
$ 19.37万 - 项目类别:
相似海外基金
Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns
尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程
- 批准号:
10518414 - 财政年份:2022
- 资助金额:
$ 19.37万 - 项目类别:
Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns
尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程
- 批准号:
10706327 - 财政年份:2022
- 资助金额:
$ 19.37万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8827703 - 财政年份:2012
- 资助金额:
$ 19.37万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
9031727 - 财政年份:2012
- 资助金额:
$ 19.37万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8629710 - 财政年份:2012
- 资助金额:
$ 19.37万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8293559 - 财政年份:2012
- 资助金额:
$ 19.37万 - 项目类别:
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse
黄曲霉毒素 B1 在 mGSTA3-/- 小鼠中的肝癌发生
- 批准号:
8464677 - 财政年份:2012
- 资助金额:
$ 19.37万 - 项目类别:
Monoclonal antibody-based electronic immunosensor for the determination of aflatoxin B1
基于单克隆抗体的电子免疫传感器测定黄曲霉毒素B1
- 批准号:
412237-2010 - 财政年份:2011
- 资助金额:
$ 19.37万 - 项目类别:
Engage Grants Program
Increased Nucleotide Excision Repair Activity of Aflatoxin-B1-N7-Guanine Adducts but not Aflatoxin-B1-Formamidopyrimidine Adducts in Livers of Mice Exposed Chronically to Aflatoxin-B1
长期暴露于黄曲霉毒素-B1 的小鼠肝脏中黄曲霉毒素-B1-N7-鸟嘌呤加合物的核苷酸切除修复活性增加,但黄曲霉毒素-B1-甲酰胺嘧啶加合物的核苷酸切除修复活性不增加
- 批准号:
240887 - 财政年份:2011
- 资助金额:
$ 19.37万 - 项目类别:
Modulation of Aflatoxin B1-induced hepatocarcinogenesis by RB loss
通过 RB 损失调节黄曲霉毒素 B1 诱导的肝癌发生
- 批准号:
7225591 - 财政年份:2006
- 资助金额:
$ 19.37万 - 项目类别: